FDA advisory committee endorses LEQEMBI
On June 8, a Food and Drug Administration (FDA) advisory committee voted unanimously in favor of recommending traditional approval for LEQEMBI, the Alzheimer’s drug […]
FDA advisory committee endorses LEQEMBI Read More »